Canine transmissible veneral tumor:etiology, diagnosis and treatment

Yıl 2021, Cilt: 5 Sayı: 1, 57 - 65, 30.04.2021

Çağla Nur Küçükbekir , Zeynep Günay Uçmak , Çağatay Tek

https://doi.org/10.30704/http-www-jivs-net.882280

Cited By: 1

Öz

Transmissible venereal tumor (TVT) is a round cell type neoplasia that is transmitted by mating and physical transfer of tumor cells. It is one of the most common benign tumors in dogs that can be seen in both gender. The external genital area is the main location of the tumor. However, internal organ metastasis has been reported. The most common clinical signs are lobular masses which are seen in the caudal part of the penis, in the posterior region of the vagina and at the vestibulovaginal junction. Nodular lesions with rapid bleeding are the most pronounced clinical finding. Initially, the small tumor forms into a large ulcerated mass in the next periods. Simultaneously, the volume of the tumor increases and the lesions are seen multilobular, cauliflower-like, brittle, hyperemic, and hemorrhagic. The most practical diagnostic method of the tumor is vaginal cytology. Cytology findings are characterized by the round or oval cells which have, pale blue or colorless cytoplasm with cytoplasmic vacuoles and a prominent nucleus. Chemotheraphy is the most effective treatment method. The weekly intravenous administration of vincristine suplhate given for 3 weeks on average reveals that the treatment success rate is beyond 90%. In this review, etiology, clinical findings, diagnosis and treatment of TVT are presented.

Anahtar Kelimeler

Dog, Neoplasia, Vagina, Vincristine

Kaynakça

• Abedin, S.N. (2020). Canine transmissible venereal tumor: A review. Journal of Entomology and Zoology Studies, 8(2): 596-599.
• Albanese., F, Poli, A., Millanta, F. & Abramo, F. (2002). Primary cutaneous extragenital canine transmissible venereal tumour with Leishmania laden neoplastic cells: a further suggestion of histiocytic origin. Veterinary Dermatology, 13: 243-246.
• Allen, S.W., Prasse, K.W. & Mahaffey, E.A. (1986). Cytologic differentiation of benign from malignant canine mammary tumours. Veterinary Pathology, 23: 649-655.
• Amber, E.I., Henderson, R.A., Adeyanju, J.B. & Gyang, E.O. (1990). Single‐Drug Chemotherapy of Canine Transmissible Venereal Tumor with Cyclophosphamide, Methotrexate, or Vincristine. Journal of Veterinary Internal Medicine, 4: 144-147.
• Andrade, S.F., Sanches, O.C., Gervazoni, E.R., Lapa, F.A.S. & Kaneko, V.M. (2009). Comparação entre dois protocolos de tratamento do tumor venéreo transmissível em cães. Clínica Veterinária, 14(82), 56-62.
• Aprea, A.N., Allende, M.G. & Idiard, R. (1994). Tumor Venéreo Transmisible Intrauterino: descripción de un caso. Veterinaria Argentina XI, 103:192-194.
• Ayala-Diaz, S., Medina, D.A.V., Lizano, M. & Manzo-Merino, J. (2017). Transmissible Cancer: A Canine Transmissible Venereal Tumor during Pregnancy, Case Report. Journal of Cancer Research, 1(1); 1-4.
• Bancroft, J.D. & Stevens, A. (1996). Theory and Practice of Histological Techniques. 3rd ed.
• Batamuzi, E.K. & Kristensen, F. (1996). Urinary tract infection: the role of canine transmissible venereal tumour. Journal of Small Animal Practice, 37: 276-279. Behera, S.K., Kurade, N.P., Monsang, S.W., Das, D.P. & Mishra, K.K. (2012). Clinico-pathological findings in a case of canine cutaneous metastatic transmissible venereal tumor. Veterinarski Arhiv, 82(4): 401 – 410.
• Birhan, G. & Chanie, M. (2015). A Review on Canine Transmissible Venereal Tumor: from Morphologic to Biochemical and Molecular Diagnosis. Academic Journal of Animal Diseases, 4(3): 185-195.
• Boscos, C.M. & Ververidis, H.N. (2004, October 6-9). TVT-Clinical findings, diagnosis and treatment. In: Proceedings of the 29th World Congress of the World Small Animal Veterinary Association. Rhodes, Greece.
• Boyd, J. (1983). The mechanisms relating to increases in plasma enzymes and isoenzymes in diseases of animals. Veterinary Clinical Pathology, 12, 9-24.
• Brandão, C.V.S., Borges, A.G., Ranzani, J.J.T., Rahal, S.C., Teixeira, C.R. & Rocha, N.S. (2002). Tumor venéreo transmissível: estudo retrospectivo de 127 casos (1998-2000). Revista de Educação Continuada, 5(1), 25–31.
• Brown, N.O., Calvert, C. & Mac Ewen, E.G. (1980). Chemotherapeutic management of transmissible venereal tumour in 30 dogs. Journal of the American Veterinary Medical Association, 176: 983–986.
• Chikweto, A., Kumtheka, S., Larkin, H., Deallie, C., Tiwari, K.P., Sharma, R.N. & Bhaiyat, M.I. (2013). Genital and extragenital canine transmissible venereal tumor in dogs in Granada, West Indies. Open Journal of Veterinary Medicine, 3 (2): 111-114.
• Costa, M.T. (1999). O tumor venéreo transmissível canino. Revista de Educação Continuadaem Medicina Veterináriae Zootecnia do CRMV – SP, 2(3): 46 – 52.
• Çeşme, H., İpek, V., Akkoç, A. & Salcı, H. (2015). Bir Köpekte Primer İntranazal Transmissible Venereal Tümör (TVT). Uludag University Journal of the Faculty of Veterinary Medicine, 1,2: 85-88.
• Daleck, C.L.M., Ferreira, H.I., Daleck, C.R. & Santana, A.E. (1987). Novos estudos sobre o tratamento do tumor venéreo transmissível canino. Ars Veterinaria, 3(2):203-209.
• Das, D., Kumthekar, S., Manikantha, K.G.V. & Achary, K.H. (2020). Sticker tumour (Transmissible venereal tumour) in dog. The Pharma Innovation Journal, SP-9(9): 126-130.
• Das, U. & Das, A.K. (2000). Review of canine transmissible venereal sarcoma. Veterinary Research Communications, 24(8): 545-556.
• De Lorimier, L.P. & Fan, T.M. (2007). Canine Transmissible Venereal Tumour. In: Withrow SJ, Vail DM (Ed). Withrow & MacEwen’s Small animal clinical oncology 4th ed. (pp. 799-804). Elsevier, USA: Saunders.
• Do Amaral, A.S., Bassani-Silva, S., Ferreira, I., Da Fonseca, L.S., De Andrade, F.H., Gaspar, L.F.J. & Rocha, N.S. (2007). Cytomorphological characterization of transmissible canine venereal tumor. Revista Portuguesa de ciências veterinárias, 102:253-260.
• Faccini, L.S., Legramanti, W.M., Castro, L.T., Coelho, A.C.B., Teixeira, M.C., Shild, A.L. & Pereira, C.M. (2019). Multiple Metastases of a Transmissible Venereal Tumor in a Dog. Acta Scientiae Veterinariae, 47(Suppl 1): 444.
• Ferreira, A.J.A., Jaggy, A., Varejäo, A.P., Ferreira, M.L.P., Correia, J.M.J., Mullas, J.M., Almeida, O., Oliveira, P. & Prada, J. (2000). Brain and ocular metastases from a Transmissible Venereal Tumour in a dog. Journal of Small Animal Practice, 41(4): 165-168.
• Ganguly, B., Das, U. & Das, A.K. (2016). Canine transmissible venereal tumour: A review. Veterinary and Comparative Oncology, 14(1): 1-12.
• Gaspar, L.F.J., Ferreira, I., Colodel, M.M., Brandao, C.V.S. & Rocha, N.S. (2010). Spontaneous canine transmissible venereal tumour: cell morphology and influence on P-glycoprotein expression. Turkish Journal of Veterinary and Animal Sciences, 34: 447-454.
• Ginel, P.J., Molleda, J.M., Novales, M., Martin, E., Margarito, J.M. & Lopez, R. (1995). Primary transmissible venereal tumor in the nasal cavity of a dog. Veterinary Record, 136 222–223.
• Gobello, C. & Corrada, Y. (2002). Effects of vincristine treatment on semen quality in a dog with a transmissible venereal tumour. Journal of Small Animal Practice, 3: 416–417.
• Gurel, A., Kuscu, B., Gulanber, E.G. & Arun, S.S. (2002). Transmissible veneral tumors detected in the extragenital organs of dogs. Israel Journal of Veterinary Medicine, 57(2):23-26.
• Günay Uçmak, Z., Kırşan, I., Uçmak, M., Erdoğan Bamaç, Ö. & Gürel, A. (2019). Clinical approaches for genital and extragenital metastasis of transmissible venereal tumor in a bitch with ovarian remnant syndrome. Ankara Üniversitesi Veteriner Fakültesi Dergisi, 417-421.
• Hayes, H.M., Biggar, R.J., Pickle, L.W., Hoover, R. & Toft, J.D. (1983). Canine transmissible venereal tumor: a model for Kaposi’s sarcoma. American Journal of Epidemiology, 117:108-109.
• Hiblu, M.A., Khabuli, N.M. & Gaja, A.O. (2019). Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya. Open Veterinary Journal, (2): 103–105.
• Higgins, D.A. (1966). Observations on the canine transmissible venereal tumor as seen in the Bahamas. Veterinary Record, 79(3):6771.
• Hithem, B., Said, B., Abdelaziz, A., Khouloud, B. & Adel, A. (2020). Surgical treatment of transmissible venereal tumor (sticker sarcoma). Bangladesh Journal of Veterinary Medicine, 18 (1): 25–29.
• Hoque, M. (1995). Different modes of therapy for canine transmissible venereal tumor. Veterinarian, 19: 1-2.
• Idowu, A.L. (1985). Cryosurgery of canine transmissible venereal tumor. Tropical Vet, 3: 74-78.
• Johnston, S.D. (1991). Performing a complete canine semen evaluation in a small animal hospital. Veterinary Clinics of North America Small Animal Practice, 21(3):545-551.
• Kabuusu, R.M., Stroup, D.F. & Fernandez, C. (2010). Risk factors and characteristics of canine transmissible venereal tumours in Grenada, West Indies. Veterinary and Comparative Oncology, 8(1): 50-55.
• Katzir, N., Rechavi, G., Cohen, J.B., Unger, T., Simoni, F., Segal, S., Cohen, D. & Givol, D. (1985). “Retroposon” insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proceedings of the National Academy of Sciences, 82: 1054–1058.
• Kerr, M.G. (2002). Clinical biochemistry and haematology. In: Veterinary Laboratory Medicine 2nd ed. (pp. 135-147). USA: Blackwell Science Ltd.
• Kolawole, B.J., Samuel, U.F., Erin, J.P. & Ifenkwe, D.C. (2020). Canine Transmissible Venereal Tumour in Four Year Old Bull Mastiff Dog: A Case Report. Animal Research International, 17(2): 3723 – 3728.
• Korystov, Y.N., Ermakova, N.V., Kublik, L.N., Levitman, M.K.H., Shaposhnikova, V.V., Mosin, V.A., Drinyaev, V.A., Kruglyak, E.B., Novik, T.S. & Sterlina, T.S. (2004). Avermectins inhibit multidrug resistance of tumor cells. European Journal of Pharmacology, 493, 57-64.
• Kroger, D., Grey, R.M. & Boyd, J.W. (1991). An unusual presentation of canine transmissible venereal tumor. Canine Practice, 16(6):17-21.
• Kumar, D., Kumar, A., Kumar, P., Lal Yadava, C. & Yadav, S.P. (2018). Ovarian remnant syndrome: A review. Journal of Entomology and Zoology Studies, 6(6): 1139-1142 Lapa, F.A.S., Andrade, S.F., Gervazoni, E.R., Kaneko, V.M., Sanches, O.C. & Lrag, F. (2012). Histopathological and cytological analysis of transmissible venereal tumor in dogs after two treatment protocols. Colloquium Agrariae, 8, 36-45.
• Liao, K.W., Lin, Z.Y., Pao, H.N., Kam, S.Y., Wang, F.I. & Chu, R.M. (2003). Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element. Journal of Veterinary Diagnostic Investigation, 15: 399–406.
• Lopes, P.D., Santos, A.C.A.A. & Silva, J.E.S. (2015). Canine transmissible venereal tumor in the genital area with subcutaneous metastases in the head - case report. Revista Portuguesa de Ciências Veterinárias, 110 (593-594) 120-123.
• Macotpet, A., Pattarapanwichien, E. & Suksawat, F. (2019). Single-Agent L-Asparagenase For The Treatment of Vincristine and Doxorubicin-Resistant Canine Transmissible Venereal Tumour. Veterinary Practitioner, 20(1).
• Martins, M.I.M., Souza, F.F. & Gobello, C. (2005). The Canine Transmissible Venereal Tumor: Etiology, Pathology, Diagnosis and Treatment. Recent Advances in Small Animal Reproduction, A1233.0405.
• Mc Evoy, GK. (1987). American Hospital Formulary Service Drug information. In: Bethesda, MD. American Society of Hospital and Pharmacists.
• Moulton, JE. (1978). Tumor of genital systems. In: Moulton JE (Ed). Tumors in domestic animals 2 ed. (pp. 326-330).California: University of California.
• Murgia, C., Pritchard, J.K., Kim, S.Y., Fassati, A. & Weiss, R.A. (2006). Clonal origin and evolution of a transmissible cancer. Cell, 126(3): 477-487.
• Novinsky, M. A. (1876). Zur Frage über die Impfung der Krebsigen Geschwülste. Zentrum für Medizinische Wissensch, 14: 790- 791.
• Ostrander, E.A., Davis, B.W. & Ostrander, G.K. (2016). Transmissible tumors: breaking the cancer paradigm. Trends Genet, 32, 1–15.
• Park, M.S., Kim, Y., Kang, M.S., Oh, S.Y., Cho, D.Y., Shin, N.S. & Kim, D.Y. (2006). Disseminated transmissible venereal tumor in a dog. Journal of Veterinary Diagnostic Investigation, 18: 130–133.
• Pouliot, J.F., L’Heureux, F., Liu, Z., Prichard, R.K. & Georges, E. (1997). Reversal of glycoprotein- P associated multidrug resistance by ivermectin. Biochemical Pharmacology, 53, 17-25.
• Purohit, G. (2009). Canine transmissible venereal tumor: A review. The Internet Journal of Veterinary Medicine, 6(1), 1-7.
• Rao, T.M., Kumar, V.G., Raghvender, K.B.P., Joshi, M.R. & Rao, R.L.N. (1993). Cryosurgical treatment of transmissible venereal tumors. Journal of Veterinary Medicine and Animal Sciences, 24: 149-152.
• Regmi, S., Mahato, P., Devkota, I., Neupane, R.P., Khulal, A. & Tiwary, A.K. (2020). A Case Report on Canine Transmissible Venereal Tumor. Journal of Zoological Research Volume Issue 02.
• Rezaei, M.S., Azizi, S., Shahheidaripour, S. & Rostami, S. (2016). Primary oral and nasal transmissible venereal tumor in a mix-breed dog. Asian Pacific Journal of Tropical Biomedicine, 6 (5): 443-445.
• Richardson, R.C. (1981). Canine transmissible veneral tumor. Compendium on Continuing Education for the Practising Veterinarian, 3: 951-956.
• Rivera, B., Ahrar, K., Kangasniemi, M.M., Hazle, J.D. & Price, R.E. (2005). Canine Transmissible Venereal Tumor: A Large-Animal Transplantable Tumor Model. Comparative Medicine Vol 55 No 4.
• Rogers, K.S. (1997). Transmissible venereal tumor. Compendium on Continuing Education for the Practising Veterinarian, 19(9):1036-1045.
• Saratsis, P.H., Ypsilantis, P. & Tselkas, K. (2000). Semen quality during vincristine treatment in dogs with transmissible venereal tumor. Theriogenology, 53(5), 1185–1192.
• Schneider, R. (1978). General Considerations. In: Moulton JE (Ed). Tumors of domestic Animals 2nd ed. (pp. 1-15). Berkeley, USA: University of California Press. Setthawongsin, C., Techangamsuwan, S., Tangkawattana, S. & Rungsipipat, A. (2016). Cell-Based Polymerase Chain Reaction for Canine Transmissible Venereal Tumor (CTVT) Diagnosis. The Journal of Veterinary Medical Science, 78(7): 1167–1173.
• Smith, G.B. (1998). Infective sarcomata in dogs. British Medical Journal, 2: 1346-1347.
• Sontaş, H., Altun, D., Turna Yılmaz, Ö., Arun, S., Şenünver, A. & Ekici, H. (2010). Bir Köpekte Eş Zamanlı Seyreden Ovaryan Remnant Sendromu, Bulaşıcı Veneral Tümör ve Stump Pyometra Olgusu. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, 16 (4): 675-680.
• Souza, V.J.T., Rorig, M.C.L., Possamai, L.M. & Ferreira, C.H. (2020). Tumor venéreo transmissível na córnea de um cão: relato de caso. Pubvet, v.14, n.6, a586, p.1-10. Stockmann, D., Ferrari, H.F., Andrade, A.L., Lopes, R.A., Cardoso, T.C. & Luvizotto, M.C.R. (2011). Canine Transmissible Venereal Tumors: Aspects Related to Programmed Cell Death. Brazilian Journal of Veterinary Pathology, 4(1), 67-75.
• Strakova, A. & Murchison, E.P. (2014). The changing global distribution and prevalence of canine transmissible venereal tumor. BMC Veterinary Research, 10 (168): 1-10.
• Tella, M.A., Ajala, O.O. & Taiwo, V.O. (2004). Complete regression of transmissible venereal tumor (TVT) in Nigerian mongrel dogs with vincristine sulphate chemotherapy. African Journal of Biomedical Research, 7(3):133-138.
• Thomson, R.G. (1984). General Veterinary Pathology. London, Philadelphia, US: W.B.Saunders Company.
• Turna Yılmaz, Ö., Uçmak, M., Günay, Z. & Kırşan, I. (2013). Vaginal fold prolapse and transmissible venereal tumour related to ovarian remnant syndrome in a bitch: a case report. Veterinary Medicine, 58 (12), 628-632.
• Uçar, M. (2016). Transmissible Venereal Tumor: A Review. Kocatepe Veterinary Journal, 9 (3):230 – 235.
• Vermooten, M.I. (1987). Canine transmissible venereal tumour (TVT): a review. Journal of the South African Veterinary Association, 58: 147-150.